2-189078540-C-G
Variant summary
Our verdict is Benign. Variant got -19 ACMG points: 0P and 19B. BP4_ModerateBP6_Very_StrongBP7BS1BS2
The NM_000393.5(COL5A2):āc.1035G>Cā(p.Gly345=) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000536 in 1,612,606 control chromosomes in the GnomAD database, including 8 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Likely benign (ā ā ). Synonymous variant affecting the same amino acid position (i.e. G345G) has been classified as Likely benign.
Frequency
Consequence
NM_000393.5 synonymous
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -19 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | UniProt |
---|---|---|---|---|---|---|---|
COL5A2 | NM_000393.5 | c.1035G>C | p.Gly345= | synonymous_variant | 16/54 | ENST00000374866.9 | |
COL5A2 | XM_011510573.4 | c.897G>C | p.Gly299= | synonymous_variant | 19/57 | ||
COL5A2 | XM_047443251.1 | c.897G>C | p.Gly299= | synonymous_variant | 21/59 | ||
COL5A2 | XM_047443252.1 | c.897G>C | p.Gly299= | synonymous_variant | 20/58 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|
COL5A2 | ENST00000374866.9 | c.1035G>C | p.Gly345= | synonymous_variant | 16/54 | 1 | NM_000393.5 | P1 | |
COL5A2 | ENST00000618828.1 | c.358+540G>C | intron_variant | 5 |
Frequencies
GnomAD3 genomes AF: 0.000710 AC: 108AN: 152144Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.00173 AC: 435AN: 251420Hom.: 3 AF XY: 0.00163 AC XY: 222AN XY: 135884
GnomAD4 exome AF: 0.000518 AC: 756AN: 1460344Hom.: 8 Cov.: 30 AF XY: 0.000533 AC XY: 387AN XY: 726554
GnomAD4 genome AF: 0.000709 AC: 108AN: 152262Hom.: 0 Cov.: 32 AF XY: 0.000846 AC XY: 63AN XY: 74438
ClinVar
Submissions by phenotype
Ehlers-Danlos syndrome, classic type, 2 Benign:2
Benign, criteria provided, single submitter | clinical testing | ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories | Jul 10, 2018 | - - |
Benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jan 13, 2018 | This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. - |
not specified Benign:1
Benign, criteria provided, single submitter | clinical testing | GeneDx | Sep 11, 2013 | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. - |
Familial thoracic aortic aneurysm and aortic dissection Benign:1
Benign, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 27, 2015 | This alteration is classified as benign based on a combination of the following: seen in unaffected individuals, population frequency, intact protein function, lack of segregation with disease, co-occurrence, RNA analysis, in silico models, amino acid conservation, lack of disease association in case-control studies, and/or the mechanism of disease or impacted region is inconsistent with a known cause of pathogenicity. - |
Ehlers-Danlos syndrome type 7A Benign:1
Likely benign, criteria provided, single submitter | clinical testing | Illumina Laboratory Services, Illumina | Jun 14, 2016 | - - |
Ehlers-Danlos syndrome, classic type, 1 Benign:1
Benign, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 29, 2024 | - - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at